Larvol Delta - A-Multicenter-Randomized-Doubleblind-Placebocontrolled-Parallelgroup-Phase-III-Study-of-HSK39004-Inhalation-Powder-for-the-Treatment-of-COPD

AN01 - AirNexis Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07583849

May 14, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next